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Autoimmune hepatitis (AIH) is a chronic inflammatory
liver disease of unknown etiology associated with circulat-
ing autoantibodies and hypergammaglobulinemia.
Patients with AIH occasionally suffer from other autoim-
mune diseases. Similarly, systemic lupus erythematosus
(SLE) is an autoimmune disorder affecting multiple
organs and coexisting with other autoimmune diseases.
Although the liver is not a major target for damage in SLE,
clinical and biochemical evidence of liver abnormalities
are common. However, the difference between the
hepatic involvement of SLE and autoimmune hepatitis
has not been clearly defined due to similarities in clinical
and biochemical features.
We report a 16-year-old girl with an overlap syndrome
involving AIH and SLE. She presented with failure to
thrive, jaundice, non-erosive arthritis, and oral aftous
lesions accompanied by hyperbilirubinemia, elevated
ALT, leukopenia, hypocomplementemia, and direct
Coombs positivity. Serologic tests showed that she was
positive for ANA and anti-Ro antibody as well as anti-glia-
din IgG and anti-endomisium IgA. Liver biopsy showed
portal and periportal hepatitis with lymphocytic infiltra-
tion and piecemeal necrosis. International autoimmune
hepatitis score demonstrated definite AIH. She had pro-
teinuria at the follow-up (77 mg/m2/hour). Autoantibod-
ies along with clinical findings fulfilled the criteria for
both AIH and SLE. Arthritis and proteinuria with hemato-
logical findings attributable to SLE improved with high
dose treatment with corticosteroids and azathioprine;
however, remission of the liver disease could not be
achieved.
In conclusion, this case suggested that AIH and SLE might
be indistinguishable from each other.
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